GEO

ANALYST NOTE: GEO (The GEO Group, Inc.) Date: 2026-06-13 Current Price: $29.28

1. Structural Readiness

State: Context-Only (Forming Coil)

• Conservative Entry: Not yet defined (awaiting confirmed breakout).
• Aggressive/Pre-Breakout Entry: Not actionable on setup alone; price is currently holding above the structural support level.
• Breakout Level: Not yet fired. The setup requires a close above the established resistance of the forming coil to transition to "Confirmed-Active."
• Current Price: $29.28.
• Extension: Not applicable (price has not yet broken out to measure extension).
• ATR Context: Current ATR is 3.5% (Productive). This sits within the historical "sweet spot" (4–6% is high, but 3.5% indicates productive volatility without the extreme risk of >8% noise).

2. Thesis Layer

Thesis Classification: Tactical / Setup-Led Secular Thesis: None named at this date.

This is a tactical trade driven by the structural setup quality and immediate business fundamentals rather than a broad, named macro secular thesis. The conviction must be derived strictly from the quality of the "Margin Inflector" archetype, the strength of the recent contract wins, and the technical structure of the price action. We do not invent a thesis; we judge the name on its ability to execute the current setup and the underlying business momentum recorded as of the source dates.

3. Business Overview

Company: The GEO Group, Inc. Industry: Prisons & Correctional Services / Government Contracting Business Model: GEO operates a diversified portfolio of secure detention facilities, community-based reentry services, and electronic monitoring solutions. The company generates revenue through long-term contracts with federal, state, and local government agencies, primarily ICE (Immigration and Customs Enforcement) and the U.S. Marshals Service.

Key Business Drivers (as of 2026-06-13):

• Contract Expansion: Management reported in the May 6, 2026 earnings transcript that in 2025, the company was awarded new or expanded contracts representing up to $520 million in incremental annual revenues, the highest single-year total in company history.
• Capacity Growth: Facility activations from these new contracts represent $300 million in annual revenues and increased the total beds under contract with ICE to approximately 26,000 beds. At full capacity, these 6,000 new beds could generate over $300 million in combined incremental revenues.
• Diversified Client Base: The company secured a new five-year contract with the U.S. Marshals Service covering 26 federal judicial districts across 14 states. Additionally, the Florida Department of Corrections issued Notices of Intent to Award managed-only contracts for three facilities (totaling ~3,854 beds).
• Operational Scale: As of December 31, 2025, the company manages/owns approximately 75,000 beds at 96 facilities.
• Revenue & Profitability: Q1 2026 (or trailing twelve months ending Feb 2026) data shows revenues of $705.2 million (up from $604.6 million) and operating income of $89.3 million (up from $61.0 million).
• Management Expectations: For full-year 2026, management expects GAAP net income to be $153 million to $166 million ($1.10 to $1.25 per diluted share) on revenues of $2.95 billion to $3.1 billion.
• Strategic Platform: The "GEO Continuum of Care" platform integrates rehabilitative programs (cognitive behavioral treatment, vocational training) and compliance technologies (RF, GPS monitoring) to offer a broader suite of services beyond simple detention.

4. Archetype and Conviction Analysis

Archetype: Margin Inflector Fit Rationale: The company is demonstrating a clear inflection in profitability driven by high-margin contract additions and capacity utilization. The shift from $604M to $705M in quarterly revenue, coupled with a jump in operating income from $61M to $89M, signals improved operating leverage. The "Margin Inflector" label fits because the company is leveraging fixed-cost infrastructure (owned/leased facilities) to absorb new, high-volume contracts, thereby expanding margins.

Valuation & Financial Spine:

• Forward Consensus: FY1 EPS consensus is $1.2275; FY2 is $1.67.
• Current Price Context: At $29.28, the stock trades at approximately 24x FY1 consensus EPS and 17.5x FY2 consensus EPS.
• Conviction Stack:
• Thesis Strength: Moderate (Tactical, no macro thesis).
• Evidence Quality: High. Multiple primary sources (earnings transcripts, SEC filings) confirm record contract awards and revenue growth.
• Structural Quality: The "Forming Coil" state suggests a healthy consolidation after a run-up, with price holding above support.
• Setup Readiness: Partial. The setup is "Forming," meaning it is a candidate for a breakout but has not yet fired.
• Rerating Potential: Moderate. The combination of record contract awards ($520M) and legislative tailwinds (OBBBA funding) provides a fundamental basis for a multiple expansion if the breakout confirms.

ATR Analysis: The current ATR of 3.5% is "productive." It is not in the "extreme" (>8%) or "very high" (6-8%) zones, suggesting the stock is not in a state of panic or excessive speculation, but rather in a controlled accumulation or consolidation phase.

5. Invalidations, Strengths, and Gaps

What Would Strengthen the Case:

• Confirmed Breakout: A daily close above the established resistance of the forming coil (price action confirmation).
• Contract Announcements: Further announcements of new ICE or Marshals contracts exceeding the $520M 2025 record.
• Guidance Raise: Management raising the 2026 EPS guidance above the $1.25 upper bound.

What Would Invalidate the Case:

• Contract Loss: A significant loss of a major contract (e.g., ICE or Marshals) that materially impacts the 26,000 bed count.
• Legislative Reversal: Any legislative action that significantly reduces the $75 billion OBBBA funding or mandates a reduction in detention capacity.

Gaps in Evidence:

• Specific Breakout Level: The exact price level for the breakout (resistance) is not provided in the data stream, only the current price and ATR.
• Debt/Capital Structure: While revenue and income are clear, specific details on debt maturity schedules or capex requirements for the new facilities are not detailed in the provided snippets.
• Margin Breakdown: While operating income is up, the specific margin percentage for the new contracts vs. legacy contracts is not explicitly quantified in the evidence.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: medium Key evidence: Record $520M in new contracts awarded in 2025; Operating income surged to $89.3M from $61.0M in recent period; Management guidance of $1.10-$1.25 EPS for 2026; Price holding above structural support in a forming coil pattern. Key risks: Technical setup remains "forming" and has not yet broken out; Dependence on federal government contracts and potential policy shifts; No named secular thesis to provide long-term tailwinds beyond tactical setup. Sizing hint: Position size should reflect the "forming" status—smaller than a confirmed breakout, but larger than a speculative guess. Expected path: Price consolidates near current levels while waiting for a catalyst to trigger a breakout above resistance, followed by a move toward the next structural target. Expected horizon: 3 to 6 months for the setup to resolve (breakout or invalidation).